Article Information
History
- April 19, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Erika T. Minetti, MS1,*,
- Hanno C. Erythropel, PhD2,*,
- Rachel Keith, ANP, PhD3,
- Danielle R. Davis, PhD4,
- Julie B. Zimmerman, PhD2,
- Suchitra Krishnan-Sarin, PhD4 and
- Naomi M. Hamburg, MD, MS1,†
- 1Evans Department of Medicine, Section of Vascular Biology, and Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, MA
- 2Department of Chemical and Environmental Engineering, Yale University, New Haven, Connecticut
- 3University of Louisville School of Medicine, Louisville, KY
- 4Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut
- ↵†Corresponding Author: Naomi M. Hamburg, MD, Whitaker Cardiovascular Institute, Boston University School of Medicine, 72 East Concord St, Boston, MA 02118, 617-638-7260, 617-414-1563 (FAX), nhamburg{at}bu.edu
↵* Authors contributed equally
Posted April 19, 2024.
Cardiovascular Health Effects and Synthetic Cooling Agents in E-cigarettes Labeled as ‘clear’ Marketed in Massachusetts After the Tobacco Product Flavoring Ban
